Tumor microcirculation evaluated by dynamic magnetic resonance imaging predicts therapy outcome for primary rectal carcinoma.

Contrast enhanced dynamic studies of malignant tumors performed by computed tomography or magnetic resonance imaging (MRI) are increasingly applied to characterize tumor microcirculation for the prediction of therapy outcome. The aim of our study was to correlate perfusion index (PI) values determined in primary rectal carcinoma before chemoradiation with therapy outcome. In 17 patients with clinically staged T3 primary rectal carcinoma, dynamic MRI was performed before the onset of therapy using an ultrafast T1-mapping sequence. On the basis of the acquired data sets, PI values were calculated on a pixel-by-pixel basis. To characterize the heterogeneity of tumor microcirculation, relative cumulative frequency histograms of PI values within the tumors were computed. Subsequent resection of the tumors allowed correlating PI with histopathological classification. In 12 of 17 patients, T-downstaging as a response to therapy was found, whereas in the remaining 5 patients no therapy response was observed after chemoradiation. A statistically significant difference between both groups was found for the mean PI (P < 0.001; 8.5+/-1.7 ml/min/100 g versus 11.4+/-0.7 ml/min/100 g). Analyzing the cumulative frequency histograms for both groups revealed an optimal discrimination for a P1 value of 12.6 ml/min/100 g. The fraction of pixels in the tumor with PI values larger than 12.6 ml/min/100 g was significantly different (P < 0.001) between therapy-responding (3+/-3.6%) and therapy-nonresponding tumors (21+/-4.3%). The results indicate either a reduced supply of nutrients as well as chemotherapeutic agents attributable to increased shunt flow or highly aggressive tumor cell clusters characterized by increased angiogenic activity. Noninvasive PI measurements by dynamic MRI in rectal carcinoma before therapy seem to be of predictive value for therapy outcome in patients scheduled for preoperative chemoradiation.

[1]  J. Folkman,et al.  Tumoral vascularity as a prognostic factor in cancer. , 1996, Important advances in oncology.

[2]  P. Okunieff,et al.  Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. , 1989, Cancer research.

[3]  J. Logue,et al.  Vascular endothelial growth factor (VEGF) expression is a prognostic factor for radiotherapy outcome in advanced carcinoma of the cervix , 2000, British Journal of Cancer.

[4]  A M Peters,et al.  Noninvasive measurement of blood flow and extraction fraction. , 1987, Nuclear medicine communications.

[5]  J. Mcdonald,et al.  Tumors of the head and neck. , 1950, The South Dakota journal of medicine and pharmacy.

[6]  M. Buyse,et al.  Efficacy of intravenous continuous infusion of fluorouracil compared with bolus administration in advanced colorectal cancer. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  L. Sobin,et al.  [Gynecologic tumors]. , 2000, Minerva ginecologica.

[8]  H. A. Eddy,et al.  Alterations in tumor microvasculature during hyperthermia. , 1980, Radiology.

[9]  E. Friedman,et al.  Tumors of the head and neck. A 4-year study of a multidisciplinary approach. , 1978, International journal of oral surgery.

[10]  H Baddeley,et al.  Dynamic contrast enhanced magnetic resonance scanning as a predictor of response to accelerated radiotherapy for advanced head and neck cancer. , 1999, The British journal of radiology.

[11]  J. Overgaard,et al.  Modification of Hypoxia-Induced Radioresistance in Tumors by the Use of Oxygen and Sensitizers. , 1996, Seminars in radiation oncology.

[12]  Klaas Dijkstra,et al.  A single-scan fourier transform method for measuring spin-lattice relaxation times , 1976 .

[13]  F. Greene.  AJCC cancer staging handbook , 2002 .

[14]  L. Sobin,et al.  Colon and Rectum , 1998 .

[15]  R Deichmann,et al.  Quantification of T1 values by SNAPSHOT-FLASH NMR imaging , 1992 .

[16]  M. Knopp,et al.  Estimating kinetic parameters from dynamic contrast‐enhanced t1‐weighted MRI of a diffusable tracer: Standardized quantities and symbols , 1999, Journal of magnetic resonance imaging : JMRI.

[17]  M. Trotter,et al.  The use of fluorescent probes to identify regions of transient perfusion in murine tumors. , 1989, International journal of radiation oncology, biology, physics.

[18]  M. Bahner,et al.  Regional blood flow, capillary permeability, and compartmental volumes: measurement with dynamic CT--initial experience. , 1999, Radiology.

[19]  J. Thrall,et al.  Tumor blood flow and systemic shunting in patients receiving intraarterial chemotherapy for head and neck cancer. , 1986, Cancer research.

[20]  G Brix,et al.  Uterine cervical carcinoma: comparison of standard and pharmacokinetic analysis of time-intensity curves for assessment of tumor angiogenesis and patient survival. , 1998, Cancer research.

[21]  R Deichmann,et al.  T1 maps by K-space reduced snapshot-FLASH MRI. , 1992, Journal of computer assisted tomography.

[22]  C Kremser,et al.  Monitoring of tumor microcirculation during fractionated radiation therapy in patients with rectal carcinoma: preliminary results and implications for therapy. , 2000, Radiology.

[23]  J. Gross,et al.  Microcirculatory studies in rat mammary carcinoma. I. Transparent chamber method, development of microvasculature, and pressures in tumor vessels. , 1980, Journal of the National Cancer Institute.

[24]  S Rees,et al.  Measurement of tissue perfusion by dynamic computed tomography. , 1992, The British journal of radiology.

[25]  W Van den Bogaert,et al.  Tumoural perfusion as measured by dynamic computed tomography in head and neck carcinoma. , 1999, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[26]  J C Ehrhardt,et al.  Tumor perfusion studies using fast magnetic resonance imaging technique in advanced cervical cancer: a new noninvasive predictive assay. , 1996, International journal of radiation oncology, biology, physics.

[27]  R K Jain,et al.  Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor/vascular permeability factor antibody. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[28]  W T Yuh,et al.  Assessment of tumor microcirculation: A new role of dynamic contrast MR imaging , 1997, Journal of magnetic resonance imaging : JMRI.

[29]  M. Kornmann,et al.  In vitro concentration response studies and in vitro phase II tests as the experimental basis for regional chemotherapeutic protocols. , 1998, Seminars in surgical oncology.

[30]  É. Lartigau,et al.  Oxygenation of Solid Tumors in Animals and Patients , 1999 .

[31]  R K Jain,et al.  Determinants of tumor blood flow: a review. , 1988, Cancer research.

[32]  L. H. Gray,et al.  The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy. , 1953, The British journal of radiology.